Abstract

Das Buch fasst die die Proceedings des 17. Kölner Workshops (Manfred Donike Workshop) zusammen. Die Autoren und ihre Beiträge sind: I. NEW ASPECTS IN DOPING ANALYSIS. 1. R.K. MUELLER, J. GROSSE, D. THIEME, R. PREISS: Banned agents and related compounds - How many ? 2. J.-C. MATHURIN, J. DE CEAURRIZ, M.-T. SICART, B. MARION, M. AUDRAN, M.-P. KRAFFT: Development of an analytical strategy for detection of perfluorocarbons (PFCs) for anti- doping control: Analysis of breath and blood samples after i.v. injection of a PFCs emulsion in rats; 3. M. THEVIS, G. OPFERMANN, W. SCHÄNZER: GC/MS-detection of hydroxyethyl starch (HES) in human urine; 4. D. DE BOER, L.J.A.L.DOS REYS, I.J. BOSMAN, R.A.A. MAES: The detection of the use of some popular hallucinogenic compounds, including those of psilocybe mushrooms; 5. U. MARECK-ENGELKE, H. GEYER, W. SCHÄNZER: Tetrahydrocannabinol (THC) in dope control; 6. D. GOUDREAULT, A. FAKIRIAN: Selegiline urinary metabolites; 7. H. GEYER, E. NOLTEERNSTING, W. SCHÄNZER: Finasteride - A substance for manipulation in dope control ?; 8. R. S. BLACK, L. D. BOWERS: A potential case of fluvoxamine-induced inhibition of caffeine metabolism; 9. B. YAP, R. KAZLAUSKAS: Corticosteroids and exercise-stress response. II. ANABOLIC AGENTS. 10. M. SAUGY, N. ROBINSON, C. CARDIS, C. SCHWEIZER, L. RIVIER, P. MANGIN, C. AYOTTE, J. DVORAK: Nandrolone metabolites in football players: Utility for in and out of competition tests; 11. B. LE BIZEC, I. GAUDIN, A. POHU, F. MONTEAU, F. ANDRE: Identification of endogenous 19-norandrosterone in human urine; 12. V.P. URALETS, P.A. GILLETTE: Over-the-counter delta5 anabolic steroids 5-androsten-3,17-dione; 5-androsten-3beta,17beta-diol; dehydroepiandrosterone and 19-dor-5-androsten-3,17-dione: Excretion studies in men; 13. R.K. MUELLER, R. PREISS, M. KRUEGER: Anabolic steroids and enhanced aggressiveness; 14. J. GROSSE, D. THIEME, R. LANG, R.K. MUELLER: Formebolone detection; 15. B. VITORIANO, D. DE BOER, C. MANZONI, A. AJENJO, L.J.A.L.DOS REYS: Preliminary results of the implementation of some metabolites of the anabolic androgenic testolactone in the screening procedures; 16. D.H. VAN DE KERKHOF, P.M. VAN DER VOORT, D. DE BOER, R.A.A. MAES: Confirmation of endogenous boldenone production: A procedure for an in vitro experiment; 17. J.-F. LEVESQUE, CH. AYOTTE: Criteria for the detection of androstenedione oral administration; 18. S. WESTWOOD, B. NOBLE, C. MOULE: Synthesis and characterisation of steroid metabolites for use as analytical reference materials; 19. R. BERGÉS, J. SEGURA, K.D. FITCH, A.R. MORTON, X. DE LA TORRE, R. VENTURA, M. MAS, M. FARRÉ: Discrimination of prohibited oral use of salbutamol in sport from authorized inhaled asthma treatment: update; 20. P.J. VAN DER MERWE: The influence of the use of multiple doses of dhea on the steroid profile; 21. J.F. LEVESQUE, C. AYOTTE: The oral administration of DHEA : The efficiency of steroid profiling . III. TECHNIQUES OF MS DETECTION AND SAMPLE PREPARATION. 22. J. ROGERSON, G.J. TROUT: GC-C-IRMS detection of steroid metabolites - some hardware considerations; 23. M. BECCHI, F. PERRET, D. FOREST, J.C. MATHURIN, J. DE CEAURRIZ: Carbone isotope ratio mass spectrometry of endogenous corticosteroids; 24. U. FLENKER, E. NOLTEERNSTING, H. GEYER, W. SCHÄNZER: A screening Method for synthetic testosterone and its precursors based on GC/C/IRMS; 25. G. TROUT, S. SOO, R. KAZLAUSKAS: A single screen for steroids using IRMS; 26. T. KUSAMRAN, X. DE LA TORRE, R. DE LA TORRE, B. RASMUSSEN, P. WILAIRAT, T. ANUKARAHANONTA: Monitoring of low concentration anabolic steroids in urine samples from the 13th Asian Games by Ion-trap GC/MS/MS; 27. M. WU, Y. ZHANG, X. LIU, C. ZHANG: CID mass spectrometric characterization of some epimeric anabolic androgenic steroids; 28. R. KAZLAUSKAS, T. HUYNH, A. STENHOUSE, S. SOO, J. TJOA, B. YAP: Automated solid phase extraction. IV. PEPTIDE HORMONES. 29. K.I. BIRKELAND, K. FISKUM, B. BJERKE, E. HAUG, P. HEMMERSBACH: Physiological and non-physiological variations in serum levels of soluble transferrin receptor - implications for use as indicator of doping with rhEPO; 30. K.R. EMSLIE, C. HOWE, G. TROUT: Measurement of urinary erythropoietin levels in athletes; 31. B. BIALAS, A. BREIDBACH, W. SCHÄNZER: Individual reference ranges for serum erythropoietin (sEPO) - Part II: Influence of long distance flying. V.- POSTER PRESENTATION. 32. X. LIU, Y. ZHANG, M. WU, C. ZHANG: The steroid profiles after oral administration of testosterone undecanoate with different Doses; 33. M.A.S. MARQUES, C.H.B. BIZARRI, J. N. CARDOSO, F.R. DE AQUINO NETO Effect of finasteride on the urinary steroid profile: A case study; 34. T. KUURANNE, M. VAHERMO, A. LEINONEN, K. KUOPPASALMI, J. TASKINEN, E. ELOVAARA, R. KOSTIAINEN: ESI-MS and MS/MS detection of the glucuronide conjugate of 17alpha-methyl-5beta-androstan-3a,17beta-diol and its d3-labelled analogue; 35. R. ARMSTRONG, S. BIDDLE, E. HOUGHTON: Highly specific, low level detection of stanozolol and metabolites using solid phase extraction and ELISA technology; 36. M.K. HENZE, G. OPFERMANN, W. SCHÄNZER: Liquid-liquid extraction-ph-profiles of selected beta-2-sympathomimetic agonists; 37. E. HABER, J. MUNOZ-GUERRA, C. SORIANO, D. CARRERAS, C. RODRIGUEZ, F.A. RODRIGUEZ: Automated preparation for screening of anabolic steroids in urine in HP 7686 prepstation system; 38. R. GRUCZA, J. SMORAWINSKI, D. KWIATKOWSKA: Application of ketoconazole test in doubtful doping cases of Polish athletes; 39. I. SEINSCH, C.V. KUK, M. MACHNIK, G. SIEBIG, S. HORNING, G. SIGMUND, A. BREIDBACH, W. SCHÄNZER Detection of nortestosterone application in horses. A screening method for nortestosterone in horse serum with a possible confirmation in urine; 40. V. CIRIMELE, P. KINTZ, A. TRACQUI, B. LUDES: Identification of 10 corticosteroids in human hair by liquid chromatography ionspray mass spectrometry; 41. A. KNIEß, R.K. MÜLLER, J. KRATZSCH: Quantitation of human growth hormone, insulin-like growth factors I and II (IGF-I and II) and IGF binding protein-2 and -3 in athletes; 42. [Blood Study of the German Antidoping Commission (ADK)] H. BÁEZ-G., C. CAMARGO-G.: The occurrence of cocaine and metabolites in hair of drug abusers. Possible determination of cut-off values; 43. XU YOUXUAN, PENG SHIQI, QIN YANG, YANG SHUMIN: Determination of urinary clopamide by using LC/APCI/MS; 44. A. POKRYWKA, D. KWIATKOWSKA, D. STANCZYK, K. CHROSTOWSKI: Midodrine (gutron) detection in urine samples. Should midodrine be added to the IOC Doping List ? Inhaltsverzeichnis